Home » Topics » Regulatory » Health Canada

Health Canada
RSS

FDA and Health Canada permit expanded access administration of Tekmira's TKM-Ebola

Sep. 23, 2014

Nexavar approved in Canada for differentiated thyroid cancer

July 8, 2014

Antibe Therapeutics receives Canadian clearance to begin phase I program for ATB-346

June 23, 2014

Health Canada accepts Ravicti NDS for priority review

June 4, 2014

Incruse Ellipta approved in Canada for COPD

April 23, 2014

Health Canada approves Alprolix for hemophilia B

March 24, 2014

Canadian approval for Lemtrada

Dec. 16, 2013

Canadian approval for Bexsero meningococcal B vaccine

Dec. 10, 2013

Imvamune smallpox vaccine approved by Health Canada

Nov. 25, 2013

Simeprevir approved in Canada for chronic HCV infection

Nov. 21, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...